Integra LifeSciences Holdings Corp: prices $450,000,000 9.500% notes due 2033

What happened On Oct 9, 2026, Integra LifeSciences Holdings Corporation issued a press release announcing the pricing of $450,000,000 aggregate principal amount of 9.500% senior secured notes due 2033 in a private placement.

Key details

• $450,000,000 aggregate principal amount of notes, 9.500% interest, due 2033.
• The press release was issued on Oct 9, 2026 and is attached to the 8-K as Exhibit 99.1.
• The company expects the interest rate on the Notes, together with the anticipated interest rates on other elements of the company’s debt refinancing plan, will result in an increase in the company’s effective interest rate near the high end of the anticipated 100-200 basis points range previously communicated by management.

Why it may matter This Current Report on Form 8-K reports Item 7.01 (Regulation FD disclosure), covering the company’s press release announcing the pricing of the Notes, and includes the press release as an exhibit under Item 9.01. A filing does not show why the insider traded or why the company acted.